77 related articles for article (PubMed ID: 14511930)
1. Whole-body positron emission tomography in patients with HIV-1 infection.
Scharko AM; Perlman SB; Pyzalski RW; Graziano FM; Sosman J; Pauza CD
Lancet; 2003 Sep; 362(9388):959-61. PubMed ID: 14511930
[TBL] [Abstract][Full Text] [Related]
2. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques.
Wallace M; Pyzalski R; Horejsh D; Brown C; Djavani M; Lu Y; Hanson JM; Mitchen JL; Perlman SB; Pauza CD
Virology; 2000 Sep; 274(2):255-61. PubMed ID: 10964769
[TBL] [Abstract][Full Text] [Related]
3. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
[TBL] [Abstract][Full Text] [Related]
4. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273
[TBL] [Abstract][Full Text] [Related]
5. Anatomical loci of HIV-associated immune activation and association with viraemia.
Iyengar S; Chin B; Margolick JB; Sabundayo BP; Schwartz DH
Lancet; 2003 Sep; 362(9388):945-50. PubMed ID: 14511927
[TBL] [Abstract][Full Text] [Related]
6. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
[TBL] [Abstract][Full Text] [Related]
7. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
[TBL] [Abstract][Full Text] [Related]
8. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
Brust D; Polis M; Davey R; Hahn B; Bacharach S; Whatley M; Fauci AS; Carrasquillo JA
AIDS; 2006 Feb; 20(4):495-503. PubMed ID: 16470113
[TBL] [Abstract][Full Text] [Related]
9. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging?
Hoegerle S; Juengling F; Otte A; Altehoefer C; Moser EA; Nitzsche EU
Radiology; 1998 Oct; 209(1):253-8. PubMed ID: 9769840
[TBL] [Abstract][Full Text] [Related]
10. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
Laubenbacher C; Saumweber D; Wagner-Manslau C; Kau RJ; Herz M; Avril N; Ziegler S; Kruschke C; Arnold W; Schwaiger M
J Nucl Med; 1995 Oct; 36(10):1747-57. PubMed ID: 7562038
[TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution inflammatory syndrome due to Mycobacterium avium complex successfully followed up using 18 F-fluorodeoxyglucose positron emission tomography-computed tomography in a patient with human immunodeficiency virus infection: A case report.
Namkoong H; Fujiwara H; Ishii M; Yagi K; Haraguchi M; Matsusaka M; Suzuki S; Asakura T; Asami T; Saito F; Fukunaga K; Tasaka S; Betsuyaku T; Hasegawa N
BMC Med Imaging; 2015 Jul; 15():24. PubMed ID: 26187282
[TBL] [Abstract][Full Text] [Related]
13. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
14. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer.
Sun SS; Chen TC; Yen RF; Shen YY; Changlai SP; Kao A
Anticancer Res; 2001; 21(4B):2957-61. PubMed ID: 11712793
[TBL] [Abstract][Full Text] [Related]
15. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
[TBL] [Abstract][Full Text] [Related]
16. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
[TBL] [Abstract][Full Text] [Related]
19. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy.
Haberkorn U; Strauss LG; Dimitrakopoulou A; Seiffert E; Oberdorfer F; Ziegler S; Reisser C; Doll J; Helus F; van Kaick G
J Nucl Med; 1993 Jan; 34(1):12-7. PubMed ID: 8418251
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of a short acquisition protocol for whole-body positron emission tomography with fluorine-18 fluorodeoxyglucose.
Paul AK; Tatsumi M; Fujino K; Hashikawa K; Nishimura T
Eur J Nucl Med; 2001 Nov; 28(11):1697-701. PubMed ID: 11702113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
